Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Cell cycle proteins as promising targets in cancer therapyNature reviews. Cancer, 2017-02, Vol.17 (2), p.93-115 [Peer Reviewed Journal]COPYRIGHT 2017 Nature Publishing Group ;COPYRIGHT 2017 Nature Publishing Group ;Copyright Nature Publishing Group Feb 2017 ;ISSN: 1474-175X ;EISSN: 1474-1768 ;DOI: 10.1038/nrc.2016.138 ;PMID: 28127048Full text available |
|
2 |
Material Type: Article
|
Ocular Toxicity of Targeted Anticancer AgentsDrugs (New York, N.Y.), 2021-05, Vol.81 (7), p.771-823 [Peer Reviewed Journal]The Author(s), under exclusive licence to Springer Nature Switzerland AG 2021 ;Copyright Springer Nature B.V. May 2021 ;ISSN: 0012-6667 ;EISSN: 1179-1950 ;DOI: 10.1007/s40265-021-01507-z ;PMID: 33788182Full text available |
|
3 |
Material Type: Article
|
Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1)Cancer discovery, 2017-04, Vol.7 (4), p.400-4092017 American Association for Cancer Research. ;ISSN: 2159-8274 ;EISSN: 2159-8290 ;DOI: 10.1158/2159-8290.cd-16-1237 ;PMID: 28183697Full text available |
|
4 |
Material Type: Article
|
Mule/Huwe1/Arf-BP1 suppresses Ras-driven tumorigenesis by preventing c-Myc/Miz1-mediated down-regulation of p21 and p15Genes & development, 2013-05, Vol.27 (10), p.1101-1114 [Peer Reviewed Journal]Copyright © 2013 by Cold Spring Harbor Laboratory Press 2013 ;ISSN: 0890-9369 ;EISSN: 1549-5477 ;DOI: 10.1101/gad.214577.113 ;PMID: 23699408Full text available |
|
5 |
Material Type: Article
|
Signal Transducer and Activator of Transcription 3 Is the Dominant Mediator of the Anti-Inflammatory Effects of IL-10 in Human MacrophagesThe Journal of immunology (1950), 2004-01, Vol.172 (1), p.567-576 [Peer Reviewed Journal]ISSN: 0022-1767 ;EISSN: 1550-6606 ;DOI: 10.4049/jimmunol.172.1.567 ;PMID: 14688368Full text available |
|
6 |
Material Type: Article
|
Picking the point of inhibition: a comparative review of PI3K/AKT/mTOR pathway inhibitorsMolecular cancer therapeutics, 2014-05, Vol.13 (5), p.1021-1031 [Peer Reviewed Journal]ISSN: 1535-7163 ;EISSN: 1538-8514 ;DOI: 10.1158/1535-7163.mct-13-0639 ;PMID: 24748656Full text available |
|
7 |
Material Type: Article
|
Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's diseaseMedicinal research reviews, 2013-01, Vol.33 (1), p.139-189 [Peer Reviewed Journal]2011 Wiley Periodicals, Inc. ;Copyright © 2012 Wiley Periodicals, Inc. ;ISSN: 0198-6325 ;EISSN: 1098-1128 ;DOI: 10.1002/med.20248 ;PMID: 21793014 ;CODEN: MRREDDFull text available |
|
8 |
Material Type: Article
|
Combinations with Allosteric SHP2 Inhibitor TNO155 to Block Receptor Tyrosine Kinase SignalingClinical cancer research, 2021-01, Vol.27 (1), p.342-354 [Peer Reviewed Journal]2020 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-20-2718 ;PMID: 33046519Full text available |
|
9 |
Material Type: Article
|
A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor XaNature medicine, 2013-04, Vol.19 (4), p.446-451 [Peer Reviewed Journal]COPYRIGHT 2013 Nature Publishing Group ;COPYRIGHT 2013 Nature Publishing Group ;Copyright Nature Publishing Group Apr 2013 ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/nm.3102 ;PMID: 23455714Full text available |
|
10 |
Material Type: Article
|
The Global Phosphorylation Landscape of SARS-CoV-2 InfectionCell, 2020-08, Vol.182 (3), p.685-712.e19 [Peer Reviewed Journal]2020 Elsevier Inc. ;Copyright © 2020 Elsevier Inc. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;Attribution - NonCommercial ;2020 Elsevier Inc. 2020 Elsevier Inc. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2020.06.034 ;PMID: 32645325Digital Resources/Online E-Resources |
|
11 |
Material Type: Article
|
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: EnzymesBritish journal of pharmacology, 2019-12, Vol.176 (S1), p.S297-S396 [Peer Reviewed Journal]2019 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of The British Pharmacological Society. ;2019. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0007-1188 ;EISSN: 1476-5381 ;DOI: 10.1111/bph.14752 ;PMID: 31710714Full text available |
|
12 |
Material Type: Article
|
Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseasesNature reviews. Rheumatology, 2017-04, Vol.13 (4), p.217-233 [Peer Reviewed Journal]COPYRIGHT 2017 Nature Publishing Group ;COPYRIGHT 2017 Nature Publishing Group ;Copyright Nature Publishing Group Apr 2017 ;ISSN: 1759-4790 ;EISSN: 1759-4804 ;DOI: 10.1038/nrrheum.2017.22 ;PMID: 28275260Full text available |
|
13 |
Material Type: Article
|
Angiogenesis Inhibitors: Current Strategies and Future ProspectsCA: a cancer journal for clinicians, 2010-07, Vol.60 (4), p.222-243 [Peer Reviewed Journal]Copyright © 2010 American Cancer Society, Inc. ;(c) 2010 American Cancer Society, Inc. ;Copyright Lippincott Williams & Wilkins Jul/Aug 2010 ;ISSN: 0007-9235 ;EISSN: 1542-4863 ;DOI: 10.3322/caac.20075 ;PMID: 20554717 ;CODEN: CAMCAMFull text available |
|
14 |
Material Type: Article
|
Anticytokine Agents: Targeting Interleukin Signaling Pathways for the Treatment of AtherothrombosisCirculation research, 2019-02, Vol.124 (3), p.437-450 [Peer Reviewed Journal]2019 American Heart Association, Inc. ;ISSN: 0009-7330 ;EISSN: 1524-4571 ;DOI: 10.1161/CIRCRESAHA.118.313129 ;PMID: 30702995Full text available |
|
15 |
Material Type: Article
|
Small-molecule inhibitors of the receptor tyrosine kinases: promising tools for targeted cancer therapiesInternational journal of molecular sciences, 2014-08, Vol.15 (8), p.13768-13801 [Peer Reviewed Journal]Copyright MDPI AG 2014 ;2014 by the authors; licensee MDPI, Basel, Switzerland. 2014 ;ISSN: 1422-0067 ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms150813768 ;PMID: 25110867Full text available |
|
16 |
Material Type: Article
|
In Silico Evaluation of the Effectivity of Approved Protease Inhibitors against the Main Protease of the Novel SARS-CoV-2 VirusMolecules (Basel, Switzerland), 2020-05, Vol.25 (11), p.2529 [Peer Reviewed Journal]2020. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 by the authors. 2020 ;ISSN: 1420-3049 ;EISSN: 1420-3049 ;DOI: 10.3390/molecules25112529 ;PMID: 32485894Full text available |
|
17 |
Material Type: Article
|
Target and Agent Prioritization for the Children's Oncology Group-National Cancer Institute Pediatric MATCH TrialJNCI : Journal of the National Cancer Institute, 2017-05, Vol.109 (5) [Peer Reviewed Journal]The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com. ;The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com. 2017 ;ISSN: 0027-8874 ;EISSN: 1460-2105 ;DOI: 10.1093/jnci/djw274 ;PMID: 28376230Full text available |
|
18 |
Material Type: Article
|
Verteporfin inhibits growth of human glioma in vitro without light activationScientific reports, 2017-08, Vol.7 (1), p.7602-8, Article 7602 [Peer Reviewed Journal]2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2017 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-017-07632-8 ;PMID: 28790340Full text available |
|
19 |
Material Type: Article
|
Biological and Pharmacological Activities of 1,3,4-Thiadiazole Based CompoundsMini reviews in medicinal chemistry, 2015-01, Vol.15 (9), p.762-775 [Peer Reviewed Journal]ISSN: 1389-5575 ;EISSN: 1875-5607 ;DOI: 10.2174/1389557515666150519104057 ;PMID: 25985954Full text available |
|
20 |
Material Type: Article
|
A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve ReplacementThe New England journal of medicine, 2020-01, Vol.382 (2), p.120-129 [Peer Reviewed Journal]Copyright © 2019 Massachusetts Medical Society. All rights reserved. ;Copyright © 2019 Massachusetts Medical Society. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1911425 ;PMID: 31733180Full text available |